Abstract: A large pool of clinicians are needed to meet the growing demand for HIV preexposure prophylaxis. We surveyed a mixed group of HIV specialists and nonspecialists in the San Francisco Bay Area to determine their attitudes toward and training needs regarding prescribing preexposure prophylaxis to persons at increased risk of HIV infection. Willingness to prescribe was associated with experience in caring for HIV-infected patients (adjusted odds ratio 4.76, 95% confidence interval: 1.43 to 15.76, P = 0.01). Desire for further training was associated with concerns about drug resistance (P = 0.04) and side effects (P = 0.04) and was more common among noninfectious disease specialists. Clinicians favored online and inperson training methods.
INTRODUCTION
On the basis of randomized controlled trials, [1] [2] [3] preexposure prophylaxis (PrEP) consisting of daily oral emtricitabine/tenofovir (FTC/TDF) was approved by the US FDA in 2012 for use as HIV prevention in adults at increased risk of HIV infection. This was followed by comprehensive clinical guidelines from the Centers for Disease Control and Prevention in 2014 4 and endorsement of PrEP in the 2015 update to the National HIV/AIDS Strategy. 5 Recent data suggest an increase in PrEP knowledge and uptake among at-risk populations in several US cities and states, 6, 7 although a nationally representative sample of primary care providers found that one-third of them were unaware of PrEP. 8 As community interest in this highly effective strategy grows, diffusion of PrEP will require a sufficient number of providers who are knowledgeable and willing to prescribe it. Given that approximately 30% of eligible persons in San Francisco are estimated to have taken PrEP between 2013 and 2014 9 and both public 10 and private 11, 12 providers in San Francisco have documented burgeoning enrollment in their programs, understanding regional provider readiness to prescribe PrEP is critical to ensure that provider supply is well matched to patient demand.
The national discussion about provider capacity to offer PrEP is being heightened by recent estimates that more than 1.2 million Americans at risk of HIV are eligible to receive it, comparable with the number of HIV-infected individuals eligible for antiretroviral treatment. 13 To meet this demand for PrEP, health systems will need to engage a large pool of providers, including primary care physicians. Many HIV specialists assert that primary care offices should be the principal venues for PrEP implementation, whereas many primary care providers contend that specialists' knowledge of antiretroviral therapy (ART) make them better suited as PrEP providers, a "purview paradox" 14 that must be solved if we are to realize the personal and public health benefits of this promising biobehavioral HIV prevention strategy. 14, 15 We surveyed a diverse group of primary care providers and HIV specialists in the San Francisco Bay Area, as a region that has seen early adoption of PrEP, to better understand their current PrEP prescribing behaviors, any concerns about PrEP, and educational needs to inform local training and capacity building efforts in support of further PrEP diffusion.
METHODS
A 20-item electronic, structured questionnaire was emailed to primary care providers in May 2014 through the 9-county San Francisco Bay Area Collaborative Research Network (SFBCRN: www.SFBayCRN.org) comprising community and private practice providers engaged by the University of California, San Francisco (UCSF) Clinical Translational Science Institute, and to HIV specialists, some of whom are infectious disease (ID) trained, at the San Francisco General Hospital and UCSF Medical Center HIV clinics. Main questionnaire domains included sociodemographics and practice characteristics, assessment of patients' PrEP eligibility, intention to prescribe PrEP, concerns about PrEP, and desire for training and preferred methods to obtain additional information about PrEP. Participants were offered a $30 gift certificate for survey completion; nonresponders were emailed 3 reminder invitations. Questionnaire data were collected, automatically deidentified, and labeled with study codes using Qualtrics software (Qualtrics LLC, Provo, UT). Multivariate analyses were performed to assess the association between the main outcome variable (intention to prescribe PrEP, defined as would be definitely or highly likely to prescribe PrEP to an HIV-uninfected patient without medical contraindications) and sociodemographic and practice variables, PrEP knowledge, and prior prescribing behaviors. The final model incorporated predictors significantly associated with the outcome at a P value #0.10 and age. All statistical analyses were performed using STATA version 9.0 (STA-TA Corp, College Station, TX). The study was approved by the Committee on Human Research at the UCSF.
RESULTS

Provider Characteristics
Of the 686 providers contacted to complete the survey, 608 were general primary care providers and 78 were HIV specialist providers at San Francisco General Hospital and UCSF. Overall, 99 (14%) completed the survey (89% physicians, 9% nurse practitioners, and 2% physician assistants) and were included in subsequent analyses (Table 1) . Prescribers' median age was 43 years, more than half were female, and a majority (69%) described themselves as white, whereas 24% were Asian, 2% black, and 8% Latino (race/ethnicity was not mutually exclusive). More than two-thirds (69%) of the providers surveyed cared for a mix of HIV-infected and HIVuninfected patients in their practices, whereas 20% saw HIV-uninfected patients exclusively, and 10% saw HIVinfected patients exclusively; 12% specialized in ID. More than 75% had practiced medicine for 5 or more years. Practice sites included academic (36%) and community (28%) clinics, private offices (14%), public health clinics (11%), and health maintenance organizations (3%). Most providers accepted a mix of public insurance plans, including Medicaid (90%), Medicare (87%), or city-/ county-sponsored health plans (63%); 68% accepted uninsured patients. 
Provider Experience With and Attitudes Toward PrEP
Almost all clinicians had heard of PrEP (92%), although only 26% had prescribed it. Nevertheless, most providers (70%) were very or somewhat confident in prescribing PrEP to patients with ongoing risk of HIV infection and no medical contraindications. When asked to which patients they would prescribe PrEP, most clinicians identified patients at increased risk in accordance with CDC guidelines 4 : men who have sex with men (MSM) and women with an HIV-infected male partner (91% and 92%, respectively); women with multiple partners (88%); MSM with inconsistent condom use during receptive anal sex (83%); MSM with multiple partners (78%); and MSM with inconsistent condom use during insertive anal sex (71%). While not specifically identified in the guidelines as an eligible target population, but known to be a population at significant risk, 16 69% would prescribe to male-tofemale transwomen. When asked how likely they were to prescribe PrEP to a patient with ongoing risk of HIV and no medical contraindications, 77 (79%) were definitely or very likely to do so. In bivariate analysis (Table 1) , experience in treating HIV-infected patients was associated with high (definitely or very likely) willingness to prescribe (P = 0.0003), and while not statistically significant, it seems that ID specialty and prior PrEP prescribing may be associated with willingness (P = 0.056 and 0.051, respectively). Clinicians reported concerns about PrEP (Fig. 1A) , the most common being toxicity/side effects (75%), acquiring antiretroviral resistance (60%), and adherence (58%). There was no association between willingness to prescribe and any of the concerns reported about PrEP (data not shown).
In a multivariate logistic model including age, prior PrEP prescribing, ID specialty, and caring for HIV-infected patients, high willingness to prescribe was independently associated with caring for HIV-infected patients (adjusted odds ratio 4.76, 95% confidence interval [CI]: 1.43 to 15.76, P = 0.01). 
Provider Interest in Receiving Training on PrEP
Almost two-thirds of providers (65%) wanted further training on PrEP. Wanting further training was associated with having concerns about drug resistance (odds ratio 2.43, 95% CI: 1.02 to 5.80, P = 0.04) and side effects (odds ratio 2.5, 95% CI: 1.01 to 6.19, P = 0.04), but not with other concerns (adherence, toxicity, cost, and sexual risk behavior). Although desire for PrEP training was more common among those who had never prescribed PrEP (68%, vs 54% among those who had prescribed), for non-ID specialists (67%, vs 50% among ID specialists), or did not care for HIV-infected patients (70%, vs 64% among those caring for HIV-infected patients), none of these associations reached statistical significance. As seen in Figure 1B , the most common training topics of interest were HIV testing frequency (88%), contraindications to PrEP use (86%), laboratory monitoring (86%), PrEP eligibility (84%), and adherence counseling (81%). More non-ID clinicians than ID specialists, however, wanted training in adherence counseling (84% vs 50%, P = 0.04) and PrEP side effects and toxicities (74% vs 17%, P = 0.004). There was a trend for more non-ID specialists compared with ID specialists to want additional training in sexual behavior counseling related to PrEP (55% vs 17%, P = 0.072). Providers expressed interest in a mix of training methods, including self-directed, online training in the form of web-based repositories of clinical (47%) and counseling (40%) guidelines, or eLearning courses (35%). Almost a third (31%) still desired face-to-face training and expressed interest in accessing a telephone warm line to seek clinical support (30%).
DISCUSSION
In this online survey, we found that San Francisco Bay Area clinicians were highly aware of PrEP and willing to prescribe it to eligible adults. Approximately a quarter of the sample, largely composed of non-ID specialist primary care providers, had previously prescribed PrEP, vs fewer than 10% of primary care providers in a national survey in 2015. 16 The San Francisco Bay Area prescribing experience may reflect early regional awareness about PrEP which began over a decade ago with the conduct of PrEP safety and efficacy trials, 17 the completion of a large demonstration project conducted at the municipal sexually transmitted disease clinic, 10, 18 and rapid uptake by several local health care organizations. 19 The tempo of PrEP use nationally may be increasing: recently presented national prescribing data indicate a surge in PrEP (738% from 2012 to 2015), 7 similar to that observed earlier in San Francisco 11 ; cities with the highest number of PrEP starts in 2015 were, in order, New York City, San Francisco, Chicago, and Washington, DC. 7 As in other studies in the Northeastern United States and nationwide, 15, 16, 20 we found that provider experience in caring for HIV-infected individuals was highly associated with willingness to prescribe. Thus, to accelerate regional PrEP provider capacity in the face of growing user demand, public health practitioners should initially target support to primary care providers with HIV care experience and primary care clinics with panels of patients at risk of infection based on recent HIV diagnoses. This strategy may be warranted in other early HIV epicenters where generalists often care for individuals living with HIV and may also see the seronegative partners of their HIV-infected patients or other patients who may be eligible to receive PrEP.
We also found that a majority of providers surveyed wanted additional training on PrEP. Providers' training needs centered on clinical issues: toxicities and side effects, the potential for drug resistance, and adherence. These likely reflect concerns, even among ART-experienced providers, about giving antiretroviral drugs to HIV-uninfected patients. It is understandable that primary care providers less experienced with antiretrovirals seemed especially interested in training on adherence, side effects, and toxicities. As providers in our study preferred both in-person and selfdirected training, public health detailing 21 that involves brief, interactive, face-to-face training with providers may be a useful strategy as it may increase the likelihood of PrEP prescribing. 22 In addition, the availability of the National Clinical Consultation Center Warmline for HIV providers, recently expanded to include PrEP, 23 should be promoted. Self-directed online learning resources that include updated guidelines, clinical protocols, and instructional videos could also be disseminated.
This study had limitations. The response rate for this online provider survey was relatively low, although consistent with several studies using this strategy. [24] [25] [26] [27] The overall low response rate may have introduced bias as respondents may have already had strong interest in PrEP, thereby overestimating willingness to prescribe. However, approximately 3 quarters had still not prescribed it and a large proportion harbored concerns about PrEP and identified significant training needs, suggesting that this group may reflect the larger group of providers that would benefit from targeted outreach and capacity building and not just innovators or early adopters. 28 In addition, mid-level practitioners were underrepresented in our sample, and given their important role in providing PrEP in several settings, 16, 22 future assessments of their attitudes and training needs should be pursued as they may differ from physicians. Although providers correctly identified persons at increased risk of HIV infection, including high-risk heterosexual women, subgroups such as female partners of people who inject drugs and commercial sex workers were not explicitly listed, and future assessments should query providers regarding their readiness to identify these individuals and provide PrEP to maximize the benefit of this strategy to all women at risk. Finally, the generalizability of our findings may be limited to urban epicenters where it is common for primary care practices to care for both HIV-infected and HIV-uninfected patients. 16 Despite concerns about PrEP, this sample largely consisting of primary care providers expressed willingness to prescribe PrEP to patients at increased risk of HIV infection. Early outreach to clinicians with experience in caring for HIV-infected patients may be an efficient method for rapid PrEP expansion and should include training that focuses on clinical issues to incorporate
